Accelrys, Inc. 

(Public, NASDAQ:ACCL)   Watch this stock   
Find more results for ACCL
Nov 5, 2009
Q2 2010 Earnings Conference Call - Webcast
Nov 5, 2009
Q2 2010 Earnings Release
Aug 27, 2009
Shareholders Meeting
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 9.24% 0.12%
Operating margin 9.24% -0.39%
EBITD margin - 4.26%
Return on average assets 5.01% 0.06%
Return on average equity 8.91% 0.12%
Employees 364 -

Address

10188 Telesis Court Suite 100
San Diego, CA 92121
United States - Map
+1-858-7995000 (Phone)
+1-858-7995100 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Accelrys, Inc. discussions

  View all discussions »

Description

Accelrys, Inc. develops and commercializes scientific business intelligence software and solutions that enable its customers in the discovery and development of new drugs and materials. Its customers include pharmaceutical, biotechnology and other life science companies, as well as companies that are in the energy, chemicals, aerospace and consumer packaged goods markets. The Company’s software and service solutions are used by its customers’ scientists, biologists, chemists and information technology professionals in order to aggregate, mine, integrate, analyze, simulate, manage and interactively report scientific data. The Company designs, develops, markets and supports software based solutions that facilitate the discovery and development of new and improved products. Using the Company’s solutions, its customers create and obtain real time access to scientific data that enables them to make informed decisions.

Officers and directors

Kenneth L. Coleman Jr.
Chairman of the Board
Age: 66
Bio & Compensation - Reuters
Scipio M. Carnecchia
President, Chief Executive Officer, Director
Age: 46
Bio & Compensation - Reuters
Rick E. Russo
Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation - Reuters
Frank K. Brown Ph.D.
Chief Science Officer, Senior Vice President
Age: 50
Bio & Compensation - Reuters
David R. Mersten
Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation - Reuters
Ilene M. Vogt
Senior Vice President - Worldwide Sales and Services
Age: 50
Bio & Compensation - Reuters
Judith Ohrn Hicks
Vice President - Human Resources
Age: 45
Bio & Compensation - Reuters
Mathew A. Hahn Ph.D.
Vice President - Research & Development
Age: 49
Bio & Compensation - Reuters
Ricardo B. Levy Ph.D.
Director
Age: 64
Bio & Compensation - Reuters
Christopher J. Steffen
Director
Age: 67
Bio & Compensation - Reuters